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As a member of the tenascin family of extracellular matrix
glycoproteins, tenascin-R is located exclusively in the CNS. It
is believed to play a role in myelination and axonal stabiliz-
ation and, through repulsive properties, may contribute to
the lack of regeneration of CNS axons following damage. The
contrary functions of the tenascins have been localized to the
different structural domains of the protein. However, little is
known concerning the influence of the carbohydrate conju-
gated to the many potential sites for N- and O-glycosylation
(10–20% by weight). As a first analytical requirement, we
show that >80% of the N-glycans in tenascin-R are neutral
and dominated by complex biantennary structures. These
display the “brain-type” characteristics of outer-arm- and
core-fucosylation, a bisecting N-acetylglucosamine and, sig-
nificantly, an abundance of antennae truncation. In some
structures, truncation resulted in only a single mannose
residue remaining on the 3-arm, a particularly unusual
consequence of the N-glycan processing pathway. In contrast
to brain tissue, hybrid and oligomannosidic N-glycans were
either absent or in low abundance. A high relative abundance
of O-linked sialylated glycans was found. This was associated
with a significant potential for O-linked glycosylation sites
and multivalent display of the sialic acid residues. These
O-glycans were dominated by the disialylated structure,
NeuAcα2–3Galβ1–3(NeuAcα2–6)GalNAc. The possibility
that these O-glycans enable tenascin-R to interact in the CNS
either with the myelin associated glycoprotein or with sia-
loadhesin on activated microglia is discussed.
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Introduction
Tenascin-R (TN-R), originally named J1-160/180, janusin, in
rodents (Kruse et al., 1985; Pesheva et al., 1989, 1993) and
restrictin in chicken (Rathjen et al., 1991) is a member of the
tenascin multigene family of structurally-related, modular glyco-
proteins of the extracellular matrix (ECM) (Chiquet-Ehrismann,
1995). Molecules of the ECM play a key role in the development,
maintenance, and repair of the nervous system (Reichardt and
Tomaselli, 1991; Ruoslahti, 1996). The tenascins are multifunctional
molecules that can either promote or inhibit cell adhesion and
neurite outgrowth in specific assays (Faissner and Kruse, 1990;
Morganti et al., 1990; Lochter et al., 1991; Erickson, 1993; Taylor
et al., 1993; Lochter and Schachner, 1997). They are prominent
in the development of the nervous system, where both adhesive
and anti-adhesive interactions between neurons and the ECM are
essential in neuronal pattern formation.
TN-R is detected exclusively in the CNS, where it is expressed
by oligodendrocytes and subpopulations of neuronal cells
(Pesheva et al., 1989; Bartsch et al., 1993; Wintergerst et al.,
1993). The protein appears mostly associated with the surface of
oligodendrocytes and myelinated axons in the white matter and
with perineuronal nets of interneurons and motoneurons in
different parts of the mammalian CNS (Pesheva et al., 1989;
Bartsch et al., 1993; Angelov et al., 1998). This pattern of TN-R
expression suggests a role in the process of CNS myelination,
stabilization, and maintenance of nerve fiber tracts and axosomatic
synaptic contacts, the latter required for normal connectivity and
neuronal survival. TN-R has been shown to be adhesive for
oligodendrocytes (sulfatide-mediated; Pesheva et al., 1997) and
astrocytes (Pesheva et al., 1989; Morganti et al., 1990) and anti-
adhesive for activated microglia (Angelov et al., 1998) and CNS
neurons (Pesheva et al., 1989, 1993; Taylor et al., 1993). The
latter action is mediated by the interaction of TN-R with the
neuronal protein F3/F11/contactin (Pesheva et al., 1993; Xiao et al.,
1996, 1997b, 1998), which also acts as a receptor for the 190 kDa
isoform of tenascin-C (TN-C) (Zisch et al., 1992). The
F3/F11-mediated inhibition of neurite outgrowth by TN-R (and
probably TN-C) may also contribute to the marked lack of
regeneration of CNS axons following injury. The contrary
functions of tenascins localize to different structural domains of
the molecule (Erickson, 1993; Schachner et al., 1994; Faissner
and Schachner, 1995; Faissner et al., 1996; Norenberg et al.,
1996; Fischer et al., 1997).
TN-R is composed of four structural motifs. The N-terminus,
unique to the tenascin family, contains a cysteine-rich segment
followed by EGF-like repeats (4.5 for TN-R) and eight motifs
related to fibronectin type III-like domains. At the C-terminus,
TN-R contains a 220 amino acid segment similar to the β and γ
chains of fibrinogen, including a Ca2+ binding segment (Norenberg
et al., 1996; Carnemolla et al., 1996). Rat, chicken, and human
TN-R (Norenberg et al., 1992; Fuss et al., 1993; Carnemolla et al.,
1996) show a high degree of sequence homology (typically at
least 75%), including conservation of potential sites for N-glyco-
sylation (14 in the rat). There are also numerous potential sites for
O-glycosylation, the proportions of serine and threonine in
several of the fibronectin type III domains indicating, moreover,
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Fig. 1. WAX-HPLC of the total glycans released from TN-R. Fractions were
collected, as shown at the bottom of the figure, into neutrals and pools 1–5.
The column void and the elution positions of mono-, di-, tri-, and
tetra-sialylated N-linked glycans obtained from fetuin are indicated at the top.
regions for potential O-linked domains (Wilson et al., 1991).
Although tenascins contain in the region of 10–20% by weight of
carbohydrate, nearly all structural and functional analyses to date
have concentrated exclusively on the polypeptide. The possibility
that binding between lecticans (e.g., the chondroitin sulfate
proteoglycans versican, brevican) and TN-R may be mediated
through a C-type lectin–carbohydrate interaction has been
studied. However, the potential role of the glycoconjugate ligands
of TN-R (e.g., the HNK-1 carbohydrate, containing a 3-sulfated
glucuronic acid; see Schachner and Martini, 1995, for review)
remained unclear (Aspberg et al., 1995, 1997).
For an understanding of the details of molecular interactions
involving the glycans of TN-R, it is first necessary to describe the
nature of the glycosylation of the glycoprotein. The results are
presented in this paper for TN-R prepared from adult mouse brain
and their potential biological significance is discussed.
Results
The total N- and O- linked glycans, released by hydrazinolysis,
were subjected to weak anion-exchange (WAX) HPLC (Figure 1).
A major, voided peak of neutral glycans was observed, followed
by peaks eluting in the mono- to tri- sialyl region of the
chromatogram (fractions 1–4), as determined by reference to
standard sialylated glycans obtained from fetuin. Subsequently,
a broad spectrum of components was seen, in low abundance,
eluting from the tri-sialyl to the more highly charged regions of
the chromatogram (fraction 5). The WAX HPLC partially
resolves components according to size as well as charge, with
smaller structures being retained to a greater extent than larger
structures with the equivalent number of charges (Guile et al., 1994).
Neutral N-glycans
The Bio-Gel P4 profile of neutral N-linked glycans from TN-R,
obtained from the WAX HPLC void fraction, is shown in
Figure 2. Most (>80%) of the N-linked glycans released from
TN-R were neutral (data not shown; retarded, acidic fractions of
WAX HPLC, Figure 1, were mainly O-linked glycans; see
below). Fractions a–f were collected preparatively as shown
(Figure 2) and were analyzed by normal phase (NP-) and reverse
phase (RP-) HPLC, matrix-assisted laser desorption/ionization
(MALDI-) MS and exoglycosidase sequencing as described
previously (Chen et al., 1998). The NP-HPLC profiles of P4
fractions a, c, d, and e/f are shown in Figure 3 and MALDI-MS
data obtained from most of the NP-HPLC peaks are in Table I. P4
fraction b, as a shoulder of c (Figure 2), gave a similar NP-HPLC
profile (not shown) to c (Figure 3). Overall the NPGU values
(Figure 3), isobaric monosaccharide compositions (Table I), and
sequential effects of the enzymatic digestions indicated that
“truncated complex biantennary glycans (Figure 4), similar or
identical to those identified as major components of rat brain
tissue (Chen et al., 1998) were particularly abundant. Truncation
of the 3-arm as far as the mannose was observed in some
structures, based on the use of Diplococcus pneumoniae β-hexo-
saminidase at arm-specific concentrations in the presence of a
bisecting GlcNAc (see Materials and methods). The “boxed”
structures shown in Figure 4 were major components of the
neutral N-linked glycan pool from TN-R.
Table I. Masses and compositions of the neutral N-linked glycans found in
TN-R arranged in order of complexity
Mass1 Comp.2
No.3 Fract.4 Found Calc. H N F
1 ef 1377.6 1377.5 5 2 0
2 ef 1540.0 1539.6 6 2 0
3 ef — 1256.5 3 3 0
4 ef 1402.5 1402.6 3 3 1
5 ef 1460.2 1459.6 3 4 0
6 d,c 1605.4 1605.4 3 4 1
7 c 1605.7 1605.4 3 4 1
8 c 1768.2 1767.7 4 4 1
9 c 1913.9 1913.7 4 4 2
10 b 1784.1 1783.7 5 4 0
11 b 1930.3 1929.7 5 4 1
12 c 1808.7 1808.7 3 5 1
13 b 1971.4 1970.8 4 5 1
14 b — 2132.8 5 5 1
15 b — 2116.8 5 5 2
16 a 2149.0 2148.8 6 5 0
1Monoisotopic mass of the MNa+ ion. Masses in italics were recorded with
the AutoSpec instrument, other masses were recorded with the Voyager
instrument. -, Minor compound (Figure 4) analyzed by sequential
exoglycosidase digestion only.
2Monosaccharide composition: H, hexose (mannose, galactose); N, HexNAc
(GlcNAc); F, deoxyhexose (fucose).
3Compound number for structure in Figure 4.
4P4 Fraction (Figure 2). Due to poor resolution on Bio-Gel P4, many of the
compounds found in Fraction c (nos. 7, 8, 9, and 12) also contributed
significantly to Fraction b.
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Fig. 2. BioGel P4 chromatogram of the neutral N-linked oligosaccharides from TN-R. Fractions a-f were pooled as shown for further analysis. The numbers at the
top indicate the elution positions of glucose oligomers (P4 glucose units, P4GU) from a partial dextran hydrolysate, 2AB-labeled. Due to a slight charge
interaction with the matrix, the presence of the 2AB-fluorescent label decreases the glucose unit value of a given oligosaccharide by 2.65 compared with the
corresponding nonlabeled alditol. The void volume containing acidic glycans is not shown.
Oligomannosidic glycans Man(6–5)GlcNAc2 were the main
components of P4 fractions e and f, respectively, and were the
only constituents detected from this glycan family. Thus, in
contrast to brain tissue, larger oligomannosidic glycans
Man(9–7)GlcNAc2 were completely absent from TN-R, as were
hybrid structures.
P4 fraction b contained a complex mixture of the more highly
processed outer-arm- and core-fucosylated biantennary struc-
tures ± bisecting GlcNAc (Figure 4), similar to those in whole
brain (Chen et al., 1998) and in fraction c (Figure 3). Fraction a
contained a single component identified as a (2,4)-branched
galactosylated triantennary glycan without either outer-arm or
core fucosylation. Digestion with Diplococcus pneumoniae
β-galactosidase removed three Gal residues. The product coeluted
by HPLC with a (2,4)-branched agalactosylated triantennary
structure and was sensitive to digestion with Diplococcus
pneumoniae β-hexosaminidase at 0.01 U/ml with the removal of
two β(1,2)-linked GlcNAc residues. This structure (though
present as a minor constituent) had not been observed as a major
component in the whole brain (Chen et al., 1998). It is possible
that partially galactosylated, outer-arm fucosylated triantennary
glycans such as found in rat brain (Chen et al., 1998) were
contained in pool b, but these would only have been present as
trace components.
Acidic glycans
Acidic N- and O- linked glycans were voided on the BioGel P4
column and were separated analytically by NP-HPLC (Figure 5a).
Essentially all components eluting after the void and by 65 min
(depicted by the horizontal bar) were O-linked glycans. The
later-eluting region contained the much less abundant N-linked
oligosaccharides. Separation of the acidic glycans, primarily by
charge, was performed by WAX-HPLC and was illustrated in
Figure 1. Each acidic pool was collected separately and was
analyzed by NP-HPLC. This was coupled, in specific cases, with
exoglycosidase sequencing and the following results were
obtained.
WAX pools 1 and 2. These relatively minor pools of the WAX
HPLC profile (Figure 1) contained essentially N-linked and O-
linked glycans, respectively, as was indicated by the corresponding
late and early retention times on NP-HPLC (not shown). Resis-
tance of these profiles to change after incubation of the glycan
fractions with Arthrobacter ureafaciens neuraminidase indicated
that, in both cases, the carbohydrates were not sialylated but
carried a different monoanionic charge (see Discussion).
WAX pool 3. This pool revealed homogeneity on NP-HPLC
(Figure 5b) and showed complete neutralization after digestion
with NDV neuraminidase. The 2-aminobenzamide (2-AB)-la-
beled product was identified by RP-HPLC (by reference to the
standard profile in Figure 6a) as the monosaccharide galactose
(not shown; see Discussion) and the original glycan as NeuAc
α2–3 Gal.
WAX pool 4. This pool also showed homogeneity on NP-HPLC
(Figure 5c). Incubation with Newcastle disease virus (NDV)
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Fig. 3. NP-HPLC profiles of neutral N-glycan fractions from TN-R.
Fractions shown are pools a, c, d, and e & f from BioGel P4 chromatography
(see Figure 2). Numbers adjacent to peaks indicate compound number in
Figure 4 (and Table I). Symbols: triangles, fucose; solid squares, GlcNAc;
open circles,  mannose; open squares, galactose. The numbers at the top of
the NP-HPLC profiles indicate the elution positions of glucose oligomers
(normal phase glucose units, NPGU) from a partial dextran hydrolysate,
2AB-labeled.
Fig. 4. Structures of the neutral N-glycans of TN-R. The compound numbers
correspond to those given in Table I and to those peak numbers given in
Figure 3. Components in boxes represent the most abundant glycans.
neuraminidase caused a loss of one NeuAc residue (not shown),
and subsequent digestion with Arthrobacter ureafaciens neu-
raminidase produced complete neutralization. The neutral product
coeluted with standard 2AB-labeled Galβ1–3GalNAc on both NP-
and RP-HPLC. It was resistant to incubation with jack bean
β-galactosidase but was digested by bovine testes β-galactosi-
dase. Confirmation of the 2AB-labeled carbohydrate residue as
GalNAc was provided by RP-HPLC (Figure 6b). The structure
NeuAcα2–3Galβ1–3(NeuAcα2–6)GalNAc was therefore pro-
posed. This was confirmed when the glycan coeluted with the
authentic disialylated oligosaccharide (see Materials and
methods) on NP- and RP- HPLC. Further confirmation was
obtained in parallel studies using the glycan labeled with tritium
in its reduced state. In this case, the reducing terminal monosac-
charide was detected as its alditol acetate by gas chromatographic
analysis (data not shown).
WAX pool 5. This broad pool of minor components contained a
mixture of N- and O-linked glycans. All appeared to be sialylated
as there was a substantial change in the NP-HPLC profile after
A.ureafaciens neuraminidase digestion (not shown). However, no
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Fig. 5. NP-HPLC profiles of 2AB-labeled acidic glycans of TN-R. (a) Total
acidic glycans. The horizontal bar indicates the elution period for O-linked
glycans. (b) WAX pool 3. (c) WAX pool 4. The numbers at the top indicate
the elution positions of glucose oligomers (NPGU) from a partial
hydrolysate of dextran, 2AB-labeled.
glycans were neutralized by this treatment, indicating that all
contained at least one other type of anionic charge.
The acidic N-glycans, detected in WAX pools 1 and 5 only,
were present in a relatively low overall abundance and showed a
high degree of structural heterogeneity. More than 90% contained
charged groups other than or in addition to NeuAc. On account
of the low abundance and complexity of these structures, further
analysis was not performed.
Discussion
This study addresses the characterization of the most abundant
glycans expressed on TN-R from adult mouse brain. The glycans
comprised neutral N-linked oligosaccharides and O-linked sialylated
structures.
Fig. 6. RP-HPLC of 2AB-labeled monosaccharides. (a) Profile for a mixture
of common standard monosaccharides. Abbreviations: Fuc, fucose; Xyl,
xylose; Gal, galactose; Glc, glucose; Man, mannose; Arab, arabinose;
GlcNAc, N-acetylglucosamine; GalNAc, N-acetylgalactosamine. (b) Profile
for the reducing terminal monosaccharide of the component in WAX pool 4.
The peak has a retention time corresponding to that of 2AB-labeled GalNAc.
N-Linked glycans
The neutral N-linked glycans comprised >80% of the N-linked
oligosaccharide pool and consisted mainly of complex biantennary
structures with outer-arm and core fucosylation, bisecting
GlcNAc residues and arm truncation. The truncated complex
biantennary glycans were major components of TN-R and are
highlighted as boxed structures in Figure 4. These glycans were
detected earlier in whole brain tissue (Shimizu et al., 1993; Chen et
al., 1998). The involvement of N-acetylglucosaminyltransferase I in
substituting the 3-arm mannose with GlcNAc is a prerequisite for
subsequent N-glycan processing, and it was proposed that the
absence of this monosaccharide may indicate the presence of a
novel, specific β-hexosaminidase in brain tissue (Shimizu et al.,
1993; Chen et al., 1998). The present results indicate that such a
specific activity is likely to be prevalent in oligodendrocytes from
which cell type TN-R is mainly expressed.
In contrast to brain tissue (Chen et al., 1998), hybrid structures
were not expressed on TN-R. Moreover, oligomannosidic
glycans, known to be expressed on several neural glycoproteins
(Fahrig et al., 1990; Horstkorte et al., 1993), including synaptic
glutamate receptors (Clark et al., 1998), were relatively minor
components, consisting only of Man(6–5)GlcNAc2. Thus, the
N-glycan processing pathway was directed almost entirely
towards the production of complex oligosaccharides only. This
suggested that there was an extensive array of processing
enzymes in the oligodendrocyte cell and good accessibility to the
glycosylation sites on TN-R for the completion of the processing.
TN-R contained one complex glycan, in addition to those
described above, which was not identified as a major structure in
rat brain tissue (Chen et al., 1998). This component was a
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(2,4)-branched nonfucosylated triantennary oligosaccharide. The
sialylated counterpart of this structure was seen, however, in rat
brain (Zamze et al., 1998).
Most of the minor fraction of acidic N-glycans from TN-R
possessed anionic charges in addition to NeuAc, with <10%
containing NeuAc, either α2,3- or α2,6-linked, as their sole
charged group. In accordance with this observation, TN-R is
known to express the L2/HNK-1 epitope (Kruse et al., 1985;
Pesheva et al., 1989), a characteristic carbohydrate structure of
many neural glycoproteins based on a terminal 3-sulfated
glucuronic acid moiety. It is concluded that those glycans
carrying this epitope on TN-R were probably present in minor and
heterogeneous fractions.
O-Linked acidic glycans
The most striking observation of the glycosylation of TN-R was
the relatively large abundance of O-linked acidic glycans, and
particularly the disialylated structure NeuAcα2–3Galβ1–
3(NeuAcα2–6)GalNAc (WAX pool 4, Figure 1). Potential
O-linked domains (Wilson et al., 1991) could be seen within the
region of the TN-R molecule containing the fibronectin type-III
domains (Fuss et al., 1993). This type of glycosylation could be
important in giving TN-R an extended three-dimensional structure
(Jentoft, 1990) with a display of complex carbohydrates—in this
case bearing sialic acid residues—presented in multivalent form.
These would provide much higher avidities in carbohydrate–protein
interactions than in monovalent form.
WAX pool 3 (Figure 1) also contained an abundant O-linked
acidic glycan identified as NeuAcα2–3Gal. This probably
resulted from base peeling of parent structures (such as that
described above) during the hydrazinolysis procedure (Mattu et al.,
1998). The other O-linked acidic structures described were
relatively minor. Those present in WAX pool 2 (Figure 1) resisted
digestion with A.ureafaciens neuraminidase and, from the
retention time on WAX HPLC, most probably carried a single
sulfate. The minor populations in WAX pool 5 (Figure 1), with a
late retention time, were heterogeneous in their anionic charge, being
sensitive to the neuraminidase but without being neutralized. It is
possible that such O-linked structures could also carry the
L2/HNK-1 carbohydrate epitope (Yuen et al., 1997).
The myelin-associated glycoprotein (MAG) is the major
CNS-located member of the family of lectins recognizing sialic
acids (Kelm et al., 1994; Probstmeier and Pesheva, 1999). Its
specificity of recognition has been demonstrated by Yang et al.
(1996) using a variety of gangliosides and related glycosphingo-
lipids. An α2–3-N-acetylneuraminic acid residue on the terminal
galactose was necessary for binding and additional sialic acid
residues on the other core saccharides contributed significantly.
(Additional supporting evidence has been provided recently by
Strenge et al., 1998.) The physiological sugar ligands for MAG
recognition are believed to be conjugated to protein (Kelm et al.,
1994) since the interaction was trypsin-sensitive. Clearly the
multivalent display of the disialylated O-linked glycan described
above on TN-R would strongly point to this carbohydrate as a
potential ligand for MAG. This possibility is accentuated by the
fact that MAG is present in the noncompacted myelin loops at the
node of Ranvier, where tenascin is accumulating (Bartsch et al.,
1992, 1993). The elasticity of the tenascins (Oberhauser et al.,
1998) additionally would make this type of molecule ideally
suited for an intermediary role in such a process as myelination,
substantiating results using oligodendrocytic cells (Jung et al.,
1993; Pesheva et al., 1997).
In addition, the present results suggest that sialoadhesin may
represent another cellular receptor for TN-R on activated
microglia. This I-type lectin, known to favor recognition of sialic
acids in α 2–3 linkage (Crocker et al., 1991; Kelm et al., 1994),
is normally absent in the adult CNS. It becomes expressed,
however, by a subpopulation of brain microglia/macrophages
upon CNS injury (Perry et al., 1992) and is likely to mediate the
repellent action of TN-R on activated microglia reported recently,
i.e., such interaction may play a role in the proposed function of
TN-R in neuronal protection against these cells (Angelov et al.,
1998). During neurodegeneration following peripheral nerve
axotomy, the downregulation of TN-R in the perineuronal net of
motoneurons would (1) result in an impaired structural integrity
of this specialized ECM, due to a disruption of the assembly of
TN-R with ECM proteins and chondroitin sulfate proteoglycans,
such as versican and phosphacan (Celio and Blumcke, 1994;
Aspberg et al., 1997; Xiao et al., 1997a; Milev et al., 1998), and,
as a consequence, (2) affect neuronal function and/or survival.
Materials and methods
Materials
All exoglycosidases were purchased from Oxford GlycoSciences
(Abingdon, Oxon, UK) except for Charonia lampas α-fucosidase
which was prepared in the Oxford Glycobiology Institute.
Oligosaccharide standards were obtained from Oxford Glyco-
Sciences and were fluorescently labeled with 2-AB as described
below. Additional standards were prepared by exoglycosidase
digestion of A2G0FB with Diplococcus pneumoniae β-hexo-
saminidase, 0.01 U/ml, to remove selectively the GlcNAc residue
linked to the Man α(1–3)-arm, and digestion of A2G0FB with
C.lampas α-fucosidase to remove core fucose. A disialylated
tetrasaccharide standard, NeuAcα2–3Galβ1–3(NeuAcα2–6)-
GalNAc, was obtained from IgA1 (Mattu et al., 1998).
Tenascin-R
TN-R was immunoaffinity purified from adult mouse brains as
described previously (Pesheva et al., 1989). After dialysis against
0.1 M ammonium bicarbonate pH 7.0, the sample was lyophilized
in preparation for anhydrous hydrazinolysis.
Release and labeling of oligosaccharides
The release of oligosaccharides from TN-R (1–2 mg) by small
scale hydrazinolysis was carried out essentially as described
previously (Ashford et al., 1987; Parekh et al., 1987) for the
optimal release of N- and O-linked glycans (Patel et al., 1993).
Oligosaccharides were fluorescently labeled with 2-AB by
reductive amination according to the method of Bigge et al.
(1995), using an Oxford GlycoSciences Signal labeling kit and
following the manufacturer’s instructions. Fluorescence was
measured at λem420 nm and λex330 nm.
Bio-Gel P4 gel filtration chromatography
The size fractionation of neutral glycans by Bio-Gel P4 gel
filtration chromatography in water was performed as described
previously (Ashford et al., 1987; Parekh et al., 1987). Neutral
glycans are resolved by this method and are separated from acidic
glycans which elute in the void volume of the column.
Fluorescently labeled neutral oligosaccharides were analyzed on
an Oxford GlycoSciences GlycoMap 1000 equipped with an
on-line fluorescence monitor.
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HPLC
Anion-exchange HPLC was carried out using a Vydac
301VHP575 7.5 × 50 mm WAX column (Hichrom Ltd., Reading,
UK) with ammonium formate at pH 9.0 at a flow rate of 1 ml/min
(Guile et al., 1994). The following linear stepwise gradient was
used: an increase from 0 to 25 mM formate over 12 min, followed
by increases to 105 mM over 13 min, 400 mM over 25 min,
500 mM over 5 min, and then held for 5min.
NP-HPLC of neutral 2-AB-labeled N-linked glycans was
performed using a polyhydroxyethyl aspartamide column as
described previously (Chen et al., 1998). Structures were
assigned normal phase glucose unit (NPGU) values in relation to
external calibration with a 2-AB-labeled partial hydrolysate of
dextran (Guile et al., 1996). NP-HPLC of acidic 2-AB-labeled
N- and O- linked glycans was also performed using a poly-
hydroxyethyl aspartamide column using conditions described in
Guile et al. (1996).
RP-HPLC was performed on a Hypersil BDS C18 column as
described previously (Chen et al., 1998) using 50 mM ammonium
formate as solvent A and acetonitrile as solvent B. The following
gradient conditions were used for the separation of 2-AB-labeled
N- and O-linked glycans: an increase of 2–4% B over 25 min,
followed by an increase of 4–8% B over 65 min and a further
increase of 8–12% B over 5 min. The flow rate was 0.5 ml/min.
This was then held at the final conditions for 5 min at 1 ml/min.
For the separation of 2-AB-labeled monosaccharide residues: a
linear gradient was used of 0–4% B over 50 min, followed by an
increase of 4–9% B over 42 min and a further increase of 9–12 %
B over 3 min. The flow rate was 0.5 ml/min. The final conditions
were held for 5 min at 1 ml/min.
Mass spectrometry
Positive ion matrix-assisted laser desorption/ionization (MALDI)
mass spectrometry was performed on selected peaks from the
NP-HPLC separations on either a Micromass AutoSpec-QFPD
magnetic sector mass spectrometer or a PerSeptive Biosystems
Voyager Elite mass spectrometer operated in the reflectron mode
with delayed extraction. Samples were prepared by mixing 0.5 µl
of the glycan solution, in water, with 3.0 µl (AutoSpec) or 0.5 µl
(Voyager) of a saturated solution of 2,5-DHB in acetonitrile,
allowing the mixture to crystallize and then recrystallizing it from
ethanol. Spectra were acquired on the AutoSpec instrument with
the array detector in the high resolution position to provide
monoisotopic masses. The mass range was chosen to be
appropriate to the compounds to be detected and spectra were
accumulated until a satisfactory signal:noise ratio was obtained.
During spectral acquisition, the laser spot was moved manually over
the target surface to compensate for sample depletion. Spectra on the
Voyager instrument were acquired with an accelerating voltage of
20 kV, a pulse decay of 75 ns, and a grid voltage of 70%; 256 laser
shots were fired to produce each spectrum.
Exoglycosidase digestions
The digestion of 2-AB-labeled oligosaccharides was carried out in
a volume of 20 µl for 18 h at 37C using the following enzymes:
D.pneumoniae β-galactosidase, 0.4 mU/ml in 100 mM sodium
acetate pH 5.5; bovine testes β-galactosidase 10 mU/ml in 100 mM
citrate-phosphate, pH 4.0; jack bean β-hexosaminidase 10 U/ml in
100 mM citrate-phosphate, pH5.0; Aspergillus saitoi α(1,2)-
mannosidase 1 mU/ml in 100 mM sodium acetate, pH5.0; almond
meal α-fucosidase 1 mU/ml in 100 mM sodium acetate, pH 5.0 and
Charonia lampas α-fucosidase 10 mU/ml in 50 mM sodium acetate,
pH 4.5 containing 0.15 M sodium chloride. D.pneumoniae β-hexo-
saminidase was used at either 10 U/ml or, for conditions providing
linkage specificity, at 0.01 U/ml in 100 mM citrate-phosphate,
pH 6.0 (Yamashita et al., 1992). At the lower concentration, only
GlcNAc residues linked β (1–2) to Man are cleaved, with two
provisos: (1) that β (1–2) GlcNAc is not cleaved if the Man to which
it is attached is also substituted at the C-6 position and (2) that β(1–2)
GlcNAc linked to the Man α(1–6)-arm of the tri-mannosyl core is
not cleaved in the presence of a bisecting GlcNAc.
Jack bean α-mannosidase was used at either 25 U/ml or
10 U/ml in 100 mM sodium acetate pH 5.0 containing 2 mM
Zn2+. At the lower concentration R-Manα1–6(Manα1–3)-
Manβ1–4GlcNAcβ1–4GlcNAc but not R-Manα1–3(Manα1–6)-
Manβ1–4GlcNAcβ1–4GlcNAc is susceptible where R is not H
or Man (Yamashita et al., 1980). Mixed digests of D.pneumoniae
β-galactosidase (0.4 U/ml) and almond meal α-fucosidase
(1 mU/ml) were carried out in 100 mM sodium acetate, pH 5.5.
Digestion of acidic glycans with NDV neuraminidase (specificity
for α2–3(8)NeuAc) was performed at 0.2 U/ml in 50 mM sodium
acetate, pH 5.5; and Arthrobacter ureafaciens neuraminidase
(specificity for α2–6(3,8)NeuAc) was used at 2 U/ml in either
100 mM ammonium acetate or 50 mM sodium acetate, pH 5.0.
Reactions were terminated and samples deproteinated using
0.45 µm cellulose nitrate Pro-Spin Micro centrifugal filters. After
application to the filter, samples were left at room temperature for
60 min. Glycans were then recovered by centrifugation three
times with 30 µl 5% acetonitrile.
Monosaccharide analysis
The identity of the terminal reducing monosaccharide of the
O-linked glycans was determined (1) by RP-HPLC of the
2-AB-labeled monosaccharide following complete exoglycosidase
digestion of the glycan to its reducing monosaccharide unit and
(2) by GC of the radiolabeled alditol acetate following reduction
of the glycans with 3H-labeled sodium borohydride and acid
hydrolysis (Ashford et al., 1987, and references therein).
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